Insider · CIK 0001161662
RIEDEL NORBERT G
Reports to the SEC for 8 companies · DUBLIN 4
Transactions
50
Companies
8
Filings
9
CIK
0001161662
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-31 | JAZZJazz Pharmaceuticals plcF Tax Payment | −$3,425.02 |
| 2026-08-31 | JAZZJazz Pharmaceuticals plcF Tax Payment | −$408K |
| 2026-08-05 | JAZZJazz Pharmaceuticals plcA Award | — |
| 2026-07-31 | ETONEton Pharmaceuticals, Inc. · Common StockA Award | — |
| 2026-04-21 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$91.4K |
| 2026-04-21 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$169K |
| 2026-04-21 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-04-21 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-02-27 | JAZZJazz Pharmaceuticals plcM Exercise/Conversion | +$472K |
| 2026-02-27 | JAZZJazz Pharmaceuticals plcS Sale | −$656K |
| 2026-02-27 | JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2026-02-03 | ETONEton Pharmaceuticals, Inc.X Exercise of In-Money | +$133K |
| 2026-02-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)X Exercise of In-Money | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2026-01-12 | ETONEton Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2025-08-08 | JAZZJazz Pharmaceuticals plcF Tax Payment | −$201K |
| 2025-08-07 | JAZZJazz Pharmaceuticals plcA Award | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$98.1K |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$189K |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc.M Exercise/Conversion | +$86.8K |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2025-01-03 | ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-08-06 | JAZZJazz Pharmaceuticals plcF Tax Payment | −$165K |
| 2024-08-02 | JAZZJazz Pharmaceuticals plcA Award | — |
| 2024-08-01 | Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer | — |
| 2024-08-01 | Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer | — |
| 2024-08-01 | Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2024-06-05 | Cerevel Therapeutics Holdings, Inc.A Award | — |
| 2024-02-13 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-08-14 | JAZZJazz Pharmaceuticals plcS Sale | −$171K |
| 2023-08-11 | JAZZJazz Pharmaceuticals plcA Award | — |
| 2023-06-07 | Cerevel Therapeutics Holdings, Inc.A Award | — |
| 2023-06-07 | Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award | — |
| 2023-03-03 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2023-01-03 | Aptinyx Inc.Stock Option (Right to Buy)A Award | — |
| 2022-08-08 | JAZZJazz Pharmaceuticals plcS Sale | −$166K |
| 2022-08-05 | JAZZJazz Pharmaceuticals plcM Exercise/Conversion | +$442K |
| 2022-08-05 | JAZZJazz Pharmaceuticals plcS Sale | −$1.25M |
| 2022-08-05 | JAZZJazz Pharmaceuticals plcA Award | — |
| 2022-08-05 | JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-06-14 | Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-02-07 | ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award | — |
| 2022-01-04 | Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion | — |
| 2022-01-04 | Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2021-12-06 | Aptinyx Inc.P Purchase | +$223K |
| 2021-12-02 | Aptinyx Inc.Stock Option (Right to Buy)A Award | — |
| 2021-08-06 | JAZZJazz Pharmaceuticals plcS Sale | −$193K |
| 2021-07-29 | JAZZJazz Pharmaceuticals plcA Award | — |
Recent filings
- 4RIEDEL NORBERT G0001161662-26-000008SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001161662-26-000005SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001437749-26-025696SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001437749-26-013041SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001161662-26-000002SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001437749-26-003230SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001437749-26-001301SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001765581-25-000082SEC(opens sec.gov)
- 4RIEDEL NORBERT G0001437749-25-000466SEC(opens sec.gov)
Companies
- Aptinyx Inc.Director, EXECUTIVE CHAIRMAN OF THE BOD
- ARIAD PHARMACEUTICALS INCDirector
- BAXTER INTERNATIONAL INCCorporate Vice PresidentBAX
- Cerevel Therapeutics Holdings, Inc.Director
- Eton Pharmaceuticals, Inc.DirectorETON
- GENENCOR INTERNATIONAL INCDirector
- Jazz Pharmaceuticals plcDirectorJAZZ
- OSCIENT PHARMACEUTICALS CORPDirector
Address
5TH FL, WATERLOO EXCHANGE WATERLOO RD
DUBLIN 4